Christian Bailly, Author at Oncowitan

Appointment to the Board of Directors of Alzprotect (Lille, December 5, 2024).

Dr Philippe Verwaerde (CEO of Alzprotect) announced the appointment of Prof. Christian Bailly (#Oncowitan) to the Board of Directors of Alzprotect (Lille, France) to contribute to the development of their drug candidate AZP2006 (Ezeprogind) for the treatment of progressive supranuclear palsy (PSP).

By Christian Bailly, 12 months12 December 2024 ago

News-Publications

New publication: The diversity of mackinazolinone derivatives, their syntheses and pharmacological properties.

(more…)

By Christian Bailly, 12 months11 December 2024 ago

News-Publications

New publication: The molecular diversity of proaporphine alkaloids and their properties

(more…)

By Christian Bailly, 12 months11 December 2024 ago

Gallery

Rectopanbiline® (purified bile extract), from Laboratoires du Dr Plantier (Annonay, France), 1971

(more…)

By Christian Bailly, 1 year29 November 2024 ago

Gallery

Trophirès® (myrtle and eucalyptus oils), from Laboratoires Roland-Marie S.A. (Montreuil, Fr), 1971

(more…)

By Christian Bailly, 1 year9 November 2024 ago

Gallery

Neurosthénol® (Glutamic acid), from Laboratoires M. Richard (Aubenas, Fr), 1971

(more…)

By Christian Bailly, 1 year26 October 2024 ago

Gallery

Relvene® (Trioxyethylrutin), from Laboratoires Pharmascience (Courbevoie, Fr), 1971

(more…)

By Christian Bailly, 1 year18 October 2024 ago

Gallery

Novobédouze® (hydroxocobalamine acetate), from Laboratoires Bouchara (Paris, Fr), 1971

(more…)

By Christian Bailly, 1 year13 September 2024 ago

Gallery

Entercine® (Dihydrostreptomycin sulfate, sulfaguanidine, dibromoxyquinoleine, homatropine methylbromide), from Laboratoires Robapharm (Paris, Fr), 1970

(more…)

By Christian Bailly, 1 year13 September 2024 ago